C85.84
Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-Hodgkin lymphoma (NHL) is a diverse group of blood cancers that originate in the lymphatic system, which is part of the body's immune system. The specific type designated by the ICD-10 code C85.84 refers to certain non-Hodgkin lymphomas that primarily affect the lymph nodes in the axilla (armpit) and around the upper limbs. This classification helps healthcare professionals accurately diagnose and tailor treatment strategies for affected individuals. While some forms of NHL grow slowly, others can be more aggressive, and early detection is key for effective management.
Causes & Symptoms
Clinical Causes: The exact cause of non-Hodgkin lymphoma affecting the axillary and upper limb lymph nodes remains unclear. However, several factors may increase the risk of developing this condition: - Age: Most cases are diagnosed in middle-aged and older adults. - Immune system deficiencies: Conditions like HIV/AIDS or immunosuppressive therapy post-transplant can heighten risk. - Certain infections: Some viral and bacterial infections have been linked to NHL. - Exposure to chemicals: Pesticides or certain industrial chemicals may enhance susceptibility. - Personal or family history of lymphoma or other cancers. - Autoimmune diseases: Conditions such as rheumatoid arthritis or SLE may increase risk.
Key Symptoms: Individuals with this form of non-Hodgkin lymphoma may experience various signs and symptoms, including: - Noticeable swelling or lumps in the axillary (armpit) region. - Swelling of the upper limb due to lymphatic blockage. - Persistent or unexplained pain or tenderness localized to the affected area. - Fever and night sweats. - Unintentional weight loss. - Fatigue and general weakness. - Frequent infections or a feeling of fullness in the lymph node region. - Skin changes or redness if there is local invasion or infection.
Diagnostic & Treatment
Diagnosis Path: Diagnosing non-Hodgkin lymphoma in the axilla and upper limbs involves a combination of clinical assessments and diagnostic tests: - Physical examination: Checking for swollen lymph nodes, particularly in the armpit and arm regions. - Imaging studies: Ultrasound, CT scans, or PET scans to identify the extent and location of lymph node involvement. - Biopsy: Removal of a tissue sample from a suspicious lymph node for microscopic examination is essential to confirm lymphoma type. - Blood tests: To evaluate overall health and rule out other conditions. - Bone marrow biopsy: In some cases, to determine if the lymphoma has spread to the bone marrow. - Immunophenotyping and molecular studies: To classify the specific subtype of non-Hodgkin lymphoma. Accurate diagnosis is critical for distinguishing this condition from other causes of lymphadenopathy and planning proper treatment.
Treatment Protocols: Treatment approaches for non-Hodgkin lymphoma affecting the axilla and upper limb depend on the specific subtype, stage, and overall health of the patient. Common treatment options include: - Chemotherapy: Using drugs to target and destroy lymphoma cells. - Immunotherapy: Boosting the body's immune response against cancer cells, sometimes involving monoclonal antibodies. - Radiation therapy: Targeted radiation to affected lymph node regions, especially if localized. - Targeted therapy: Employing medications that specifically target molecular abnormalities in lymphoma cells. - Stem cell transplant: Considered in some cases of aggressive or relapsed disease. - Observation: In certain indolent (slow-growing) lymphomas, a watch-and-wait approach may be suitable. The choice of treatment depends on numerous factors and is best decided by a healthcare team experienced in lymphoma management.
Clinical Advice & FAQs
Billing Guidance
Is C85.84 a billable ICD-10 code?
Yes, C85.84 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C85.84?
Clinical documentation must specify the nature of Other specified types of non-Hodgkin lymphoma, lymph nodes of axilla and upper limb and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
